Back to Browse Journals

Patient Preference and Adherence


Dr Chen

Surgery and Molecular & Cellular Biology, Baylor College of Medicine, United States

Dr Chen

Editor-in-Chief: Dr Johnny Chen

Dr Changyi (Johnny) Chen is Professor of Surgery and Molecular & Cellular Biology at the Baylor College of Medicine, Houston, Texas, USA. Currently, Dr Chen serves as Molecular Surgery Endowed Chair, Director of Molecular Surgeon Research Center, and Vice Chair for Research of the Michael E DeBakey Department of Surgery. Dr Chen received his medical degree from China in 1982 and practiced general surgery for 7 years in China. In 1989, Dr Chen immigrated to the United States for his advanced education in biomedical area and for the development of his academic career. Dr Chen received his Master of Science degree from the University of Texas at El Paso, and his PhD degree from Georgia Institute of Technology. From 1996 to 2002, Dr Chen was Assistant Professor at the Department of Surgery, Emory University, Atlanta, Georgia. Since 2002, Dr Chen has been recruited to the Baylor College of Medicine.  

Dr Chen is committed to establish an excellent research program and leadership in translational research in the field of cardiovascular disease and pancreatic cancer. Dr Chen is also committed to establishing an excellent training program for career development of junior scientists, physicians and surgeons with emphasis on promoting individual motivation, strategic planning, scientific knowledge, technique skill, and leadership quality. Dr Chen's laboratory is actively conducting several clinically relevant research projects. For example, his team is investigating the effects and molecular mechanisms of several cardiovascular risk factors including HIV protease, adipokine resistin and soluble CD40L on endothelial functions focusing on the endothelial nitric oxide synthase system, oxidative stress system, and signal transduction pathways. Different model systems are used to these investigations such as myograph, organ culture, mouse model, human tissues, and different types of endothelial cells. Dr Chen also has long term interest in vascular tissue engineering, hemodynamics, neointimal hyperplasia, and atherosclerosis. In addition, his team is heavily involved in the new program of the Personalized Genomic Medicine in cardiovascular disease and pancreatic cancer. These studies include tissue banking, genomic profiling, preclinical testing, clinical trials, and clinical applications. For example, Dr Chen has several projects focusing on the role and mechanisms of non-coding RNA genes such as microRNA 196a (miR-196a) and X-inactive specific transcript (XIST) in pancreatic cancer. Since oxidative stress plays a critical role in both cardiovascular disease and pancreatic cancer, Dr Chen has established a new program to discover new antioxidants from natural substances and existing clinical drugs, which may be used as novel therapeutic agents. Furthermore, Dr Chen is developing PLGA [poly(lactic-co-glycolic acid)]-based nanotechnology for molecular imaging and specific drug and gene delivery, which has great potential for clinical applications of molecular diagnostics and targeted therapies.

Dr Chen is a recognized expert in surgical research in the United States. He has received many major research and training grants from the National Institutes of Health and other federal and non-federal agencies. Dr Chen has more than 250 publications, 77 invited speakers or professorship, and 330 presentations at national or international scientific meetings.  He has served as multiple leadership positions in academic committees, grant study sections and editorial boards of several journals.


Dr Liu

cardiology, zhongda hospital of southeast university, China (PRC)

Dr Liu

Associate Editor - China: Naifeng Liu

Dr. Liu currently holds the position of Professor of Medicine and Consultant Cardiologist at Department of Cardiology. He is also the director of the Institute of Cardiovascular Medicine, Zhongda Hospital, Southeast University.
The research interests of Dr. Liu focus on the mechanisms of atherosclerosis and diabetic cardiovascular complications.  He has been in charge of 5 projects supported by National Natural Science Foundation of China and received 20 research grants totally from Jiangsu Province and National Ministry of education.  He has published more than 30 peer-reviewed journal papers. Due to outstanding achievement in the fields of hospital management, medical informatics and clinical pharmacy, Dr. Liu was invited and elected to many important memberships of academic society and associations in China.
 


Professor Yao

Baylor College of Medicine, United States

Professor Yao

Associate Editor: Professor Qizhi Cathy Yao

Dr. Yao is currently a professor in the Michael E. DeBakey Department of Surgery, Molecular Virology and Microbiology, Pathology and Immunology at Baylor College of Medicine; a health research scientist at center for translational research on inflammatory diseases at Michael E. DeBakey VA Medical Center in Houston, USA

Dr. Yao earned her medical degree from the Southeast University School of Medicine in China (1986) and doctoral degree from Emory University School of Medicine in Atlanta Georgia, USA. (1996). After a brief postdoctoral training in Dr. Richard Compans’ lab, she became an assistant professor in the Department of Microbiology and Immunology at Emory University School of Medicine in 1997. She was then recruited to Baylor College of Medicine as an associate professor in the Michael E. DeBakey Department of Surgery, Molecular Virology and Microbiology in 2002, and promoted to a full professor in 2007.

Dr. Yao has been actively involved in vaccine development for more than 15 years.  She is a member of many professional societies including American Society for Virology (ASV), American Association of Immunologists (AAI) and American Association for Cancer Research (AACR), etc. She is also a member of the Center for AIDS Research (CFAR) and Dan L Duncan cancer center (DLDCC).  She is one of the pioneer researchers in developing chimeric virus-like particles for HIV mucosal vaccine and pancreatic cancer immunotherapy.  Dr. Yao is currently the Principal Investigator on NIH grants, VA merit grant and several other pilot project grants, and has been collaborating with researchers at various Texas medical center institutes.   She has 196 scientific publications in the fields of Virology, Immunology, and Oncology.  She has also served on editorial board and invited reviewers in several professional journals. Dr. Yao has also served on grants review study sections nationally and internationally. Her research programs include HIV and Chagas Disease vaccine development, pancreatic cancer pathogenesis and immunotherapy.


Editorial Board

Debi Bhattacharya, Director of Enterprise and Engagement, School of Pharmacy, University of East Anglia, Norwich, Norfolk, UK

Hayden B. Bosworth, Tenure, Research Professor, Department of Medicine, Division of General Medicine, Duke University Medicine Center, Durham, NC, USA

Andrew J. Butler, Associate Dean for Research & Professor, Acting Chair Department of Physical Therapy, Byrdine F. Lewis School of Nursing & Health Professions, Georgia State University, Atlanta, GA, USA

David Cella, Ralph Seal Paffenbarger Professor and Chair, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine; Associate Director for Cancer Prevention and Control, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA

Carlos De las Cuevas, Área de Psiquiatría, Facultad de Ciencias de la Salud, Sección Medicina Universidad de La Laguna, Canary Islands, Spain

Mark Duman, MRPharmS, Director, Intelesant and Non Executive Director, Patient Information Forum, UK

Alfio Ferlito, Professor of Otorhinolaryngology-Head and Neck Surgery, Coordinator of the International Head Neck Scientific Group

Eva Kahana, Robson Professor of Sociology, Humanities, Applied Social Science, Nursing and Medicine, Director, Elderly Care Research Center, Case Western Reserve University, Cleveland, OH, USA

Ian Kellar, Associate Professor of Health Psychology, Lead for Behaviour Change Grand Challenge, School of Psychology, University of Leeds, UK

Faiz Kermani, Scientific Advisor, Health Interactions, Basel, Switzerland

George J. Knafl, Professor, School of Nursing, University of North Carolina, Chapel Hill, NC, USA

Janet Krska, Professor of Clinical and Professional Pharmacy, Universities of Greenwich and Kent at Medway, Kent, UK

Luis Lizan, CEO Outcomes´10, Castellón, Spain; Associate Professor, Department of Medicine, Jaume I University, Castellon, Spain; Royal Academy of Medicine, Valencian Community, Spain

Charles Morecroft, Professor of Pharmacy Education and Professional Practice, Liverpool John Moores University, UK

Patricia J Neafsey, Professor Emeritus, University of Connecticut; Co-Founder and Chief Scientific Officer, ActualMeds Corp, Storrs, CT, USA

Faustino R Pérez-López, Professor of Obstetrics and Gynecology, University of Zaragoza Hospital Clínico, Zaragoza, Spain

Stephen P Peters, MD, PhD, FAAAAI, FACP, FCCP, FCPP; Thomas H Davis Chair in Pulmonary Medicine; Chief, Section on Pulmonary, Critical Care, Allergy & Immunologic Diseases; Professor of Internal Medicine, Pediatrics and Translational Science; Associate Director, Center for Genomics and Personalized Medicine Research; Executive Director, Respiratory Service Line, Wake Forest Baptist Health, Winston-Salem, NC, USA

Ceib Phillips, Professor, Department of Orthodontics, University of North Carolina, Chapel Hill, NC, USA

Graham Prestwich, Lay Member – Patient and Public Involvement, NHS Leeds North Clinical Commissioning Group, UK

Patrick J. Raue, Professor of Psychology, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.

Dr. Madhukar Hariprasad Trivedi (MD), Professor, Department of Psychiatry; Chief, Division of Mood Disorders; Betty Jo Hay Distinguished Chair in Mental Health; Julie K. Hersh Chair for Depression Research and Clinical Care; Director, Center for Depression Research and Clinical Care; University of Texas Southwestern Medical Center, Dallas, TX, USA

Liset van Dijk, research coordinator of pharmaceutical care at NIVEL, the Netherlands institute for health services research (www.nivel.nl), Utrecht, the Netherlands; board member of the Center for Patient and Medication.

Leah L. Zullig, Assistant Professor of Medicine, Duke University Medical Center; Investigator, Durham VA HSR&D Center for Health Services Research in Primary Care, Durham, NC, USA